Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

citric acid/rak

Veza se sprema u međuspremnik
6 rezultatima

Cancer treatment

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION The present invention relates generally to a composition for the treatment of malignant tumors and, more specifically, to its use in a method for the treatment of carcinomas and sarcomas. BACKGROUND OF THE INVENTION Breast cancer is a malignant abnormal cell growth in the

Aqueous liquid composition

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
INCORPORATION-BY-REFERENCE OF MATERIAL ELECTRONICALLY SUBMITTED Incorporated by reference in its entirety herein is a computer-readable nucleotide/amino acid sequence listing submitted concurrently herewith and identified as follows: 5,182 bytes ASCII (Text) file named "716371SequenceListing.txt,"

Serum-free growth medium and use thereof

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION The present invention relates to a serum-free medium or medium additive which may be used in culturing cells which require iron for growth. More specifically, the present invention relates to the field of transferrin replacements in cell culture media. Methods of preparing a

Injectable composition

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
CROSS-REFERENCE TO RELATED FOREIGN APPLICATION This application claims priority under 35 U.S.C. 119 to Australian Patent No. 6074, filed Nov. 27, 1992. This invention relates to a solution of paclitaxel having improved stability. BACKGROUND OF THE INVENTION Paclitaxel is a compound extracted from

Injectable composition

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
CROSS-REFERENCE TO RELATED FOREIGN APPLICATION This application claims priority under 35 USC 119 to Australian Patent No. 6074 filed Nov. 27, 1992. BACKGROUND OF THE INVENTION Paclitaxel is a compound extracted from the bark of a western yew, Taxus brevifolia and known for its antineoplastic

Injectable composition

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
This invention relates to a solution of taxol having improved stability. BACKGROUND OF THE INVENTION Taxol is a compound extracted from the bark of a western yew, Taxus brevifolia and known for its antineoplastic activity. It is described for example in The Merck Index, Eleventh Edition 1989,
Pridružite se našoj
facebook stranici

Najkompletnija baza ljekovitog bilja potpomognuta znanošću

  • Radi na 55 jezika
  • Biljni lijekovi potpomognuti znanošću
  • Prepoznavanje bilja slikom
  • Interaktivna GPS karta - označite bilje na mjestu (uskoro)
  • Pročitajte znanstvene publikacije povezane s vašom pretragom
  • Pretražite ljekovito bilje po učincima
  • Organizirajte svoje interese i budite u toku s istraživanjem vijesti, kliničkim ispitivanjima i patentima

Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Svi podaci temelje se na objavljenim znanstvenim istraživanjima

Google Play badgeApp Store badge